OrthAlign, Inc. Announces First KneeAlign® Cases Using the All New Rotation and Soft Tissue Balancing System
Aliso Viejo, CA, Oct. 17, 2018 (GLOBE NEWSWIRE) — OrthAlign, Inc., a privately held U.S.-based medical device and technology company providing orthopedic surgeons with advanced precision technologies, announced the first cases of the KneeAlign® CFS™ system. The CFS system is an accessory that can be used during KneeAlign-assisted total knee arthroplasty (TKA) surgeries, that provides for rotation and soft tissue balancing. The cases were completed by David Mayman, M.D. at Hospital for Special Surgery in New York, NY.
OrthAlign technology provides real-time, actionable data for precise alignment and positioning of implant components. With surgical applications for Total Knee (KneeAlign®), Partial Knee (UniAlign™) and Total Hip arthroplasties (HipAlign®), OrthAlign deploys a platform of solutions directly into the surgeons’ hands via a hand-held device not much bigger than a cellphone. Now, with these new capabilities, the KneeAlign application applies the same levels of accuracy and simplicity to guiding rotation of the femoral component as well as balancing soft tissue in both the extension and flexion gaps during TKA.
“With the addition of rotation and soft tissue balancing, KneeAlign provides me with all of the information I need to achieve an aligned and balanced knee,” said David Mayman, M.D. “This now puts the capabilities of KneeAlign equal to any robotics or navigation system on the market, while at the same time being much faster, simpler, and easier to use.”
“KneeAlign has already powered more than 75,000 cases around the world, providing surgeons with the type of information that delivers confidence to their results on a daily basis,” said Eric Timko, OrthAlign’s CEO and Chairman. “After a diligent research and development process, we’re now bringing that same confidence to rotation and balance during a total knee procedure, which positions KneeAlign among the most complete navigation and robotics solutions available as we power the next 100,000 cases in the coming years.”
OrthAlign will be showcasing its full portfolio of products at this year’s AAHKS meeting in Dallas, TX, November 2-4, 2018 at booth #715.
About OrthAlign, Inc.
OrthAlign is a privately held medical device and technology company, developing advanced technologies that deliver healthier and more pain-free lifestyles to joint replacement patients, globally. We provide healthcare professionals with cutting edge, computer-assisted surgical tools that seamlessly and cost-effectively deliver vital data and clinical results to optimize outcomes for our patients. For more information regarding OrthAlign, please visit www.orthalign.com or contact Adam Simone (asimone@orthalign.com).
“ORTHALIGN®, KNEEALIGN®, HIPALIGN® and UNIALIGN™ are [registered] trademarks of OrthAlign, Inc.”
Adam Simone OrthAlign asimone@orthalign.com
